XML 41 R18.htm IDEA: XBRL DOCUMENT v3.21.2

Revenues (Tables)

9 Months Ended

Sep. 30, 2021

Segment Reporting [Abstract]

Summary of net revenue

The Company’s net revenues consisted of the following for the three and nine months ended September 30, 2021 and 2020:

			Three months ended September 30,												Nine months ended September 30,
			2021						2020						2021						2020
Products:
Kristalose			$	4,012,746					$	3,615,557					$	12,286,729					$	10,387,046
Vibativ			1,896,584						2,813,249						8,799,891						8,551,125
Caldolor			1,255,669						1,416,146						3,734,273						3,677,434
Vaprisol			325,774						406,162						1,861,130						790,817
Acetadote			368,733						218,462						638,704						1,527,173
Omeclamox-Pak			22,689						516,066						(451,683)						640,435
RediTrex			11,459						—						(13,291)						—
Other revenue			178,886						265,047						809,429						1,605,570
Total net revenues			$	8,072,540					$	9,250,689					$	27,665,182					$	27,179,600

X

- Definition

Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599

+ Details

Name:	us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration